Home Search
viaskin peanut - search results
If you're not happy with the results, please do another search
DBV Announces Promising 2-Year Results from Ongoing Viaskin “Peanut Patch” Toddler Study
81.3% of subjects who completed the oral food challenge reached an eliciting dose of ≥1,000 mg after 24 months of treatment.
Will the Viaskin “Patch” Therapy for Peanut Allergy be Approved Soon? The Company is...
Company is restructuring in anticipation of delays.
Viaskin Patch Delivers Long-Lasting Peanut Desensitization After Phase IIb Trial
The study was designed to assess the long-term efficacy and safety of the treatment in subjects that had graduated from their earlier VIPES trial.
Can Peanut Allergy Be Changed in Infancy? DBV’s THRIVE Trial Tests a Bold New...
Researchers are testing whether starting peanut patch therapy in infancy can permanently change the course of peanut allergy.
DBV Launches Peanut Patch Study in Infants as Young as Six Months
DBV Technologies has screened the first participant in a pioneering trial of its peanut allergy patch for infants.
Peanut Patch Treatment Continues to Help Toddlers Safely Build Tolerance Over Three Years
After three years of treatment, more than 70% could tolerate about three to four peanut kernels.
Children’s Response to Peanut Patch Therapy Increased Over 60 Months
VP250 may lead to an accumulation of clinical benefit with high treatment compliance, making this a valuable option for children with allergies.
Viaskin Milk Results Shows Potential for Treatment of Milk Allergy in Children
95.5% of the participants completed treatment, with most adverse effects being mild or moderate reactions at the application site.
FDA Removes Hold Allowing DBV’s Pivotal Phase 3 Peanut Patch Trial to Commence
The phase 3 trial of the modified Viaskin Peanut patch has been cleared for commencement.
Skin Patch Immunotherapy Determined Safe and Effective in Toddlers With Peanut Allergy
According to research presented at this year's #ACAAI22 meeting.
Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.
We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.
Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.
Please see our Terms of Service and Privacy Policy.
Copyright ©2011-2024 SnackSafely.com, Inc — All rights reserved